Bar-Shalev Amos bought PLX
September 3, 2026 · Form 4 insider transaction
Bar-Shalev Amos bought 8,500 shares of Protalix BioTherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
8,500
Price
$0.00
Total value
N/A
InsiderBar-Shalev Amos
RoleDirector
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateSeptember 3, 2026
Filing dateSeptember 4, 2026
Shares owned after8,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of the Isuer's common stock.; The shares of common stock underlying the RSUs vest in 12 equal quarterly installments commencing upon the date of grant.